Page 25 - GP Fall 2022_Neat

tics. J Cell Physiol. 2019;234(10):16812-16823. 29. Dézsi CA, Dézsi BB, Dézsi AD. Manage-
doi:10.1002/jcp.28350. ment of dental patients receiving antiplatelet
13. Centers for Disease Control and Prevention. therapy or chronic oral anticoagulation: A review
Coronary Artery Disease. CDC. Updated July of the latest evidence [published correction ap-
19, 2021, accessed June 6, 2022. https://www. pears in Eur J Gen Pract. 2017 Dec;23(1):i-ii].
cdc.gov/heartdisease/coronary_ad.htm. Eur J Gen Pract. 2017;23(1):196-201. doi:10.10
14. Cleveland Clinic. Coronary Artery Disease. 80/13814788.2017.1350645.
Cleveland Clinic. Updated June 21, 2021, ac- 30. Seminario-Amez M, González-Navarro B,
cessed June 6, 2022. https://my.clevelandclinic. Ayuso-Montero R, Jané-Salas E, López-López
org/health/diseases/16898-coronary-artery-dis- J. USE OF LOCAL ANESTHETICS WITH
ease. A VASOCONSTRICTOR AGENT DURING
15. Institute of Medicine (US) Committee on So- DENTAL TREATMENT IN HYPERTENSIVE
cial Security Cardiovascular Disability Criteria. AND CORONARY DISEASE PATIENTS. A
Cardiovascular Disability: Updating the Social SYSTEMATIC REVIEW. J Evid Based Dent
Security Listings. Washington (DC): National Pract. 2021;21(2):101569. doi:10.1016/j.jeb-
Academies Press (US); 2010. dp.2021.101569.
16. Cleveland clinic. Valve Disease Types. 31. Neves RS, Neves IL, Giorgi DM, Grupi CJ,
Cleveland clinic. Updated July 19, 2019, ac- César LA, Hueb W, Grinberg M. Effects of epi-
cessed June 7, 2022. nephrine in local dental anesthesia in patients
17. Centers for Disease Control and Prevention. with coronary artery disease. Arq Bras Cardiol.
Valvular Heart Disease. CDC. Updated Decem- 2007 May;88(5):545-51. English, Portuguese. Congratulations to our own
ber 9, 2019, accessed June 7, 2022. doi: 10.1590/s0066-782x2007000500008. PMID: Dr. Dalal Alhajji!
18. Cleveland clinic. Heart Valve Surgery. Cleve- 17589629.
land clinic. Updated May 1, 2022, accessed June She has made a name for herself as a
7, 2022. dental oncologist. Her many accom-
19. Buffet L, Ricchetti C. Chronic Kidney Dis- Juhee Kim is a student plishments, so early in her career, de-
ease and Hypertension: A Destructive Combina- at NYU College of Den- serve to be acknowledged.
tion. US Pharm. 2012;37(6):26-29. tistry in the class 2023.
20. Hamrahian SM, Falkner B. Hypertension Specialization in dental oncology is
in Chronic Kidney Disease. Adv Exp Med Biol. rare, and less than half of the cancer
2017;956:307-325. doi:10.1007/5584_2016_84. centers in the U.S. have dentists.
21. Pugh D, Gallacher PJ, Dhaun N. Manage-
ment of Hypertension in Chronic Kidney Dis- Angela De Bartolo, DDS
ease [published correction appears in Drugs. is a Clinical Associate Dr. Alhajji is a 2014 graduate of Boston
2020 Sep;80(13):1381]. Drugs. 2019;79(4):365- Professor at NYU Col- University Henry M. Goldman School
379. doi:10.1007/s40265-019-1064-1. lege of Dentistry in the of Dental Medicine. After earning
22. Kalaitzidis RG, Elisaf MS. Treatment of Department of Cariolo- her dental degree, she went to Case
Hypertension in Chronic Kidney Disease. Curr gy and Comprehensive Western Reserve University School
Hypertens Rep. 2018;20(8):64. doi:10.1007/ Care and she is a Group of Dental Medicine and completed an
s11906-018-0864-0. Practice Director. advanced education in general den-
23. Pistoia F, Sacco S, Degan D, Tiseo C, Ornello tistry residency and earned her Master
R, Carolei A. Hypertension and Stroke: Epidemi- Analia Veitz-Keenan, of Science in Dentistry degree in oral
ological Aspects and Clinical Evaluation. High DDS is a Clinical Pro- medicine. In 2019 she completed a
Blood Press Cardiovasc Prev. 2016;23(1):9-18. fessor at NYU College
doi:10.1007/s40292-015-0115-2. of Dentistry Department fellowship in dental oncology at Me-
24. Bavitz JB. Dental management of patients with Oral Maxillofacial Pa- morial Sloan Kettering Cancer Center.
hypertension. Dent Clin North Am. 2006;50(4):547- thology, Radiology and
vi. doi:10.1016/j.cden.2006.06.003. Medicine and Epide- After going through the fellowship in
25. Milani RV, Lavie CJ, Ventura HO. New as- miology and Health Promotion and the dental oncology, Dr. Alhajji impro-
pects in the management of hypertension in the NYSAGD President-Elect. vised to create her current role as a fac-
digital era. Curr Opin Cardiol. 2021;36(4):398- ulty member at the Department of Oral
404. doi:10.1097/HCO.0000000000000870. and Maxillofacial Pathology, Radiolo-
26. Southerland JH, Gill DG, Gangula PR, gy and Medicine at New York Univer-
Halpern LR, Cardona CY, Mouton CP. Den- sity Dentistry NYU. She is a fierce ad-
tal management in patients with hypertension: vocate for patients with cancer, which
challenges and solutions. Clin Cosmet Investig
Dent. 2016;8:111-120. Published 2016 Oct 17. contributed to her being named a 2022
doi:10.2147/CCIDE.S99446. ADA 10 Under 10 Awards winner.
27. O’Connell JE, Stassen LF. New oral anti-
coagulants and their implications for dental pa- Dr. Alhajji has created a proto-
tients. J Ir Dent Assoc. 2014;60(3):137-143. col for cancer patients to help them
28. American Dental Association. Oral Antico- navigate the disease and their oral
agulant and Antiplatelet Medications and Den- health and she works to be a voice
tal Procedures. American Dental Association. for those patients that need support.
Updated September 14, 2020, accessed June 11,
2022.
www.nysagd.org l Fall 2022 l GP 25